Matthew L.

Davis
1044 Squires Drive
West Chester, PA 19382
570-430-1092
md7e8e54@westpost.net
Endo Pharmaceuticals, January 2008 - Present
Specialty Sales Representative
Responsible for calling on Pain Specialists and Healthcare Professionals related
to pain management. Initiate protocols and work with office staff to help navig
ate managed care issues. Responsible for Opana (oxymorphone) Schedule II control
led substance. Lidoderm (lidocain patch), Voltaren Gel (diclofenac sodium topica
l gel).
Elan Pharmaceuticals, January 2005 - January 2008
Senior Sales Representative, Hospital Division
Responsible for Prialt (ziconotide) Intrathecal therapy administered via the Med
tronic SynchroMed II Infusion System and the CADD-Micro ambulatory infusion pump
. Informed pain specialists and pharmacy in the hospital environment regarding p
atient identification, indications, product ordering, and reimbursement.
Responsible for the launch of Tysabri (natalizumab) for multiple sclerosis in th
e Hospital environment. Worked with hospital pharmacists and therapeutic members
to review Tysabri and coordinated efforts with the office based sales represent
ative.
Responsible for Intravenous antibiotic sales of Maxipime (cefepime) and Azactam
(aztreonam) in the hospital environment. Work with health care professionals in
infectious disease, ICU, critical care, surgery, and pharmacy. Gain hospital for
mulary acceptance, implementation of protocols, contract pricing agreements, and
conduct educational product based in-services. Possess knowledge in a wide rang
e of therapeutic areas.
* Ranked in the top 15% (2005-2007)
* Won Directors Award Contest (2006, 215% to goal)
* Won District Award Contest (2006)
* Serve as the district computer/sales analyst
AstraZeneca Pharmaceuticals, April 1998 - January 2005
Hospital/Long Term Care Sales Representative
Responsible for inpatient intravenous antibiotic sales of Merrem (meropenem) and
Cefotan (cefotetan). Focused on healthcare care professional in infectious dise
ase, ICU, critical care, surgery, and pharmacy. Responsible for Seroquel (queti
apine) for schizophrenia/bipolar disorder in the hospital environment. Managed a
large territory focusing on gaining formulary status and developing protocols.
Developed strategies for driving sales in hospital settings as well as nursing f
acilities serviced by long term care pharmacy providers.
Cardiovascular Experience:
Promoted Diprivan in the cardiac cath lab environment. Promoted ace inhibitor Ze
stril and ca blocker Sular to cardiologists.
* Ranked in the top 10% (2003-2004)
* Achieved multiple formulary wins
* Conducted several sales and training introduction classes
* Success story appeared in company newsletter
* Recipient of several Sales Proposition Awards for assistance in sales and trai
ning
Responsible for Diprivan (propofol) Intravenous infusion for sedation in surgery
 and ICU. Work with hospital pharmacy and therapeutic members to gain hospital f
ormulary acceptance and adherence. Responsible for identifying key opinion leade
rs, presenting pricing contract agreements, developing speakers, and conducting
educational in-services.
AstraZeneca Pharmaceuticals, July 1996 - April 1998
Primary Care Sales Representative
Responsible for driving sales in the office based environment, Gain access and d
evelop relationships with physicians and office staff.
* Promoted to Hospital Sales Representative
Education
Bachelor of Arts in Biological Sciences, University of Delaware